Chandreyee Das, Author at QuartzBio

About Chandreyee Das

This author has not written his bio yet.
But we are proud to say that Chandreyee Das contributed 5 entries already.

Entries by Chandreyee Das

QuartzBio Platform Version 10.0.0: Flexibility, Efficiency and Accuracy

19 December 2024 — Before we celebrate the new year, let’s celebrate new feature releases, brought to you by the winning collaboration between QuartzBio’s product teams, managed services teams, and, most of all, our clients. This month, we released version 10.0.0 of QuartzBio’s Biomarker Intelligence Platform, delivering enhancements to the enterprise Biomarker Data Management (eBDM) […]

System and Ecosystem Interoperability: How Connectedness Drives Drug Development

Interoperability in Precision Medicine: What does it mean? In modern drug development, connectedness is crucial for success, especially in remote and decentralized teams. This connectedness involves linking people and information to extract shared insights from data and make faster decisions. In practice, this means ensuring interoperability of data, technology, systems, and ecosystems through a scalable, […]

Join QuartzBio at SCOPE 2025 | Booth #708

February 3-6, 2025 | Orlando, FL, USA If your team tackles sample management and/or biomarker operations, don’t miss this year’s SCOPE (Summit for Clinical Operations Executives) conference in Orlando! QuartzBio will be presenting “From Site to Result: Real-Time Sample Intelligence Unlocked with GenAI”12:35 PM, Tuesday, February 4, Modernizing Lab, Biomarker & Data Management Operations track […]

Protected: How to use QuartzBio’s Precision Medicine Intelligence Platform

There is no excerpt because this is a protected post.

AI-Enabled Biomarker Intelligence — QuartzBio at Bio-IT World 2024

Discussions were lively at the “Digitization of Clinical Development & Clinical Trials” symposium at last week’s Bio-IT World conference. Addressing an audience of biotech and pharma IT and data leaders, QuartzBio’s Tobi Guennel gave a provocative presentation on how deploying generative AI can amplify the ability of precision medicine approaches to accelerate drug development.